Longitudinal gray matter changes in multiple sclerosis—Differential scanner and overall disease‐related effects

Voxel‐based morphometry (VBM) has been used repeatedly in single‐center studies to investigate regional gray matter (GM) atrophy in multiple sclerosis (MS). In multi‐center trials, across‐scanner variations might interfere with the detection of disease‐specific structural abnormalities, thereby potentially limiting the use of VBM. Here we evaluated longitudinally inter‐site differences and inter‐site comparability of regional GM in MS using VBM. Baseline and follow up 3D T1‐weighted magnetic resonance imaging (MRI) data of 248 relapsing‐remitting (RR) MS patients, recruited in two clinical centers, (center1/2: n = 129/119; mean age 42.6 ± 10.7/43.3 ± 9.3; male:female 33:96/44:75; median disease duration 150 [72–222]/116 [60–156]) were acquired on two different 1.5T MR scanners. GM volume changes between baseline and year 2 while controlling for age, gender, disease duration, and global GM volume were analyzed. The main effect of time on regional GM volume was larger in data of center two as compared to center one in most of the brain regions. Differential effects of GM volume reductions occured in a number of GM regions of both hemispheres, in particular in the fronto‐temporal and limbic cortex (cluster P corrected <0.05). Overall disease‐related effects were found bilaterally in the cerebellum, uncus, inferior orbital gyrus, paracentral lobule, precuneus, inferior parietal lobule, and medial frontal gyrus (cluster P corrected <0.05). The differential effects were smaller as compared to the overall effects in these regions. These results suggest that the effects of different scanners on longitudinal GM volume differences were rather small and thus allow pooling of MR data and subsequent combined image analysis. Hum Brain Mapp, 2011. © 2011 Wiley‐Liss, Inc.

[1]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[2]  Claude Lepage,et al.  Mapping reliability in multicenter MRI: Voxel‐based morphometry and cortical thickness , 2010, Human brain mapping.

[3]  Ludwig Kappos,et al.  Spatiotemporal distribution pattern of white matter lesion volumes and their association with regional grey matter volume reductions in relapsing‐remitting multiple sclerosis , 2010, Human brain mapping.

[4]  D. Louis Collins,et al.  Evaluation of automated techniques for the quantification of grey matter atrophy in patients with multiple sclerosis , 2010, NeuroImage.

[5]  L. Kappos,et al.  Longitudinal Spatiotemporal Distribution of Gray and White Matter Pathology in Multiple Sclerosis , 2010, American Journal of Neuroradiology.

[6]  Ludwig Kappos,et al.  Effect of immunomodulatory medication on regional gray matter loss in relapsing–remitting multiple sclerosis—A longitudinal MRI study , 2010, Brain Research.

[7]  Heidi Johansen-Berg,et al.  Relationships of brain white matter microstructure with clinical and MR measures in relapsing‐remitting multiple sclerosis , 2010, Journal of magnetic resonance imaging : JMRI.

[8]  Stefan Klöppel,et al.  Intra- and interscanner variability of automated voxel-based volumetry based on a 3D probabilistic atlas of human cerebral structures , 2010, NeuroImage.

[9]  D Louis Collins,et al.  Regional impact of field strength on voxel‐based morphometry results , 2009, Human brain mapping.

[10]  M. Filippi,et al.  250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study , 2009, The Lancet Neurology.

[11]  Mara Cercignani,et al.  Exploring the relationship between white matter and gray matter damage in early primary progressive multiple sclerosis: An in vivo study with TBSS and VBM , 2009, Human brain mapping.

[12]  Marco Battaglini,et al.  Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis , 2009, Journal of the Neurological Sciences.

[13]  Joanna M. Wardlaw,et al.  Prospective multi-centre Voxel Based Morphometry study employing scanner specific segmentations: Procedure development using CaliBrain structural MRI data , 2009, BMC Medical Imaging.

[14]  David H. Miller,et al.  Imaging outcomes for neuroprotection and repair in multiple sclerosis trials , 2009, Nature Reviews Neurology.

[15]  Ludwig Kappos,et al.  Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis — A longitudinal voxel-based morphometry study , 2009, NeuroImage.

[16]  Kunio Nakamura,et al.  Segmentation of brain magnetic resonance images for measurement of gray matter atrophy in multiple sclerosis patients , 2009, NeuroImage.

[17]  F. Barkhof,et al.  Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial , 2008, The Lancet Neurology.

[18]  Graeme D. Jackson,et al.  Multi-site voxel-based morphometry: Methods and a feasibility demonstration with childhood absence epilepsy , 2008, NeuroImage.

[19]  Massimo Filippi,et al.  A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes , 2008, NeuroImage.

[20]  Clifford R. Jack,et al.  Interpreting scan data acquired from multiple scanners: A study with Alzheimer's disease , 2008, NeuroImage.

[21]  Paolo Fusar-Poli,et al.  Anterior cingulate pathology in the prodromal stage of schizophrenia , 2008, NeuroImage.

[22]  Paolo Fusar-Poli,et al.  Neurofunctional correlates of vulnerability to psychosis: A systematic review and meta-analysis , 2007, Neuroscience & Biobehavioral Reviews.

[23]  Marcus D'Souza,et al.  Structural brain abnormalities in individuals with an at-risk mental state who later develop psychosis. , 2007, The British journal of psychiatry. Supplement.

[24]  Stephen M. Smith,et al.  Regional brain atrophy development is related to specific aspects of clinical dysfunction in multiple sclerosis , 2007, NeuroImage.

[25]  R. Woods,et al.  Sex differences in cortical thickness mapped in 176 healthy individuals between 7 and 87 years of age. , 2007, Cerebral cortex.

[26]  Philip K. McGuire,et al.  Regional Gray Matter Volume Abnormalities in the At Risk Mental State , 2007, Biological Psychiatry.

[27]  Rohit Bakshi,et al.  Gray matter involvement in multiple sclerosis , 2007, Neurology.

[28]  Alan C. Evans,et al.  Focal cortical atrophy in multiple sclerosis: Relation to lesion load and disability , 2007, NeuroImage.

[29]  Alan J. Thompson,et al.  Localization of grey matter atrophy in early RRMS , 2006, Journal of Neurology.

[30]  Ludwig Kappos,et al.  Oral fingolimod (FTY720) for relapsing multiple sclerosis. , 2006, The New England journal of medicine.

[31]  Mara Cercignani,et al.  Regional gray matter atrophy in early primary progressive multiple sclerosis: a voxel-based morphometry study. , 2006, Archives of neurology.

[32]  F. Jessen,et al.  Multicenter assessment of reliability of cranial MRI , 2006, Neurobiology of Aging.

[33]  Anders M. Dale,et al.  Reliability of MRI-derived measurements of human cerebral cortical thickness: The effects of field strength, scanner upgrade and manufacturer , 2006, NeuroImage.

[34]  Clifford R Jack,et al.  Common MRI acquisition non-idealities significantly impact the output of the boundary shift integral method of measuring brain atrophy on serial MRI , 2006, NeuroImage.

[35]  Anders M. Dale,et al.  Reliability in multi-site structural MRI studies: Effects of gradient non-linearity correction on phantom and human data , 2006, NeuroImage.

[36]  Bruno Alfano,et al.  Grey matter loss in relapsing–remitting multiple sclerosis: A voxel-based morphometry study , 2006, NeuroImage.

[37]  Arthur W. Toga,et al.  Impact of acquisition protocols and processing streams on tissue segmentation of T1 weighted MR images , 2006, NeuroImage.

[38]  S. Reingold,et al.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” , 2005, Annals of neurology.

[39]  Stephen Lawrie,et al.  Empirical comparison of maximal voxel and non-isotropic adjusted cluster extent results in a voxel-based morphometry study of comorbid learning disability with schizophrenia , 2005, NeuroImage.

[40]  Cheryl L. Dahle,et al.  Regional brain changes in aging healthy adults: general trends, individual differences and modifiers. , 2005, Cerebral cortex.

[41]  G Tedeschi,et al.  Brain atrophy and lesion load in a large population of patients with multiple sclerosis , 2005, Neurology.

[42]  Zhengrong Liang,et al.  Partial volume segmentation of brain magnetic resonance images based on maximum a posteriori probability. , 2005, Medical physics.

[43]  Hans Lassmann,et al.  Cortical lesions and brain atrophy in MS , 2005, Journal of the Neurological Sciences.

[44]  A J Thompson,et al.  Gray and white matter volume changes in early RRMS , 2005, Neurology.

[45]  M. Rovaris,et al.  Regional brain atrophy evolves differently in patients with multiple sclerosis according to clinical phenotype. , 2005, AJNR. American journal of neuroradiology.

[46]  D. Louis Collins,et al.  Relating neocortical pathology to disability progression in multiple sclerosis using MRI , 2004, NeuroImage.

[47]  Thomas E. Nichols,et al.  Nonstationary cluster-size inference with random field and permutation methods , 2004, NeuroImage.

[48]  David H. Miller,et al.  Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. , 2004, Brain : a journal of neurology.

[49]  A. Dale,et al.  Focal thinning of the cerebral cortex in multiple sclerosis. , 2003, Brain : a journal of neurology.

[50]  P. M. Matthews,et al.  Evidence of early cortical atrophy in MS , 2003, Neurology.

[51]  Bruno Alfano,et al.  Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load , 2003, NeuroImage.

[52]  A J Thompson,et al.  Brain atrophy in clinically early relapsing-remitting multiple sclerosis. , 2002, Brain : a journal of neurology.

[53]  Ari Syngeniotis,et al.  Comparison of Hippocampal Volumetry at 1.5 Tesla and at 3 Tesla , 2001, Epilepsia.

[54]  Karl J. Friston,et al.  A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains , 2001, NeuroImage.

[55]  N. Andreasen,et al.  Anatomic and Functional Variability: The Effects of Filter Size in Group fMRI Data Analysis , 2001, NeuroImage.

[56]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[57]  G Schwemer,et al.  General linear models for multicenter clinical trials. , 2000, Controlled clinical trials.

[58]  Alan C. Evans,et al.  Three-Dimensional MRI Atlas of the Human Cerebellum in Proportional Stereotaxic Space , 1999, NeuroImage.

[59]  J. Ashburner,et al.  Nonlinear spatial normalization using basis functions , 1999, Human brain mapping.